期刊文献+

慢性心力衰竭患者血浆脑钠肽、肌钙蛋白Ⅰ水平监测的意义 被引量:2

下载PDF
导出
摘要 目的研究慢性心力衰竭患者血浆脑钠肽、肌钙蛋白Ⅰ水平监测的意义,为临床医生诊断慢性心力衰竭提供可靠依据。方法选择2012年12月至2013年11月来淮阳县人民医院治疗的慢性心力衰竭患者74例作为研究组,选择同期74例健康体检者作为对照组。观察两组患者脑钠肽、肌钙蛋白Ⅰ水平变化及研究组中不同NYHA级别脑钠肽、肌钙蛋白Ⅰ水平变化。结果研究组脑钠肽水平、肌钙蛋白I水平均明显高于对照组(P<0.05);不同NYHA分级脑钠肽、肌钙蛋白Ⅰ水平均不相同(P<0.05)。结论慢性心力衰竭患者的血浆脑钠肽及肌钙蛋白Ⅰ水平均高于健康人群,并且其病情越严重,血浆脑钠肽、肌钙蛋白Ⅰ水平越高,临床医生可将其作为诊断及评估病情的重要指标。
作者 张艳梅
出处 《河南医学研究》 CAS 2016年第6期1100-1101,共2页 Henan Medical Research
  • 相关文献

参考文献4

二级参考文献42

  • 1YU C M, Chan E, Sanderson J E, et al. Tissue Doppler echo - cardio- graphic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure [ J :. Circulation, 2002,105 ( 4 ) :438 - 445.
  • 2Kron J, Aranda J M Jr, Miles W M,et al. Benefit of cardiac resyn- chronization in elderly patients: results from the Multicenter InSync Randomized Clinical Evaluation(MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation(MIRACLE -ICD) trials[J]. J interv Card Electrophysiol, 2009, 25 ( 2 ) : 91 - 96.
  • 3Moss A J, Hall W J, Cannom D S, et al. Cardiac - resynchronization therapy for the prevention of heart - failure events [ J ]. N Engl J Med,2009,361 (14) :1329 - 1338.
  • 4St John Sutton M, Ghio S, Plappert T, et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure [ J ]. Circula- tion,2009,120(19) :1858 - 1865.
  • 5Reynolds C R, Gold M R. Cardiac resynchronization therapy for mild heart failure : the time has come [ J ]. Circulation, 2011,123 ( 2 ) : 195 - 202.
  • 6Tang W H, Francis G S. Cardiac resynchronization therapy in patients with class I - II heart failure and a wide QRS: a cautionary note [ J ]. Circulation, 2011,123 ( 2 ) : 203 - 208.
  • 7NDREPEPA G, BRAUN S, MEHILLI J, et al. Accuracy of N-terminal probrain natriuretic peptide to predict mortality or detect acute isehemia in patients with coronary artery disease [ J ]. Cardiology, 2008, 109 ( 4 ) : 249-257.
  • 8DICKSTEIN K, COHEN-SOLAL A, FILIPPATOS G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM) [ J]. Eur Heart J, 2008,29 ( 19 ) : 2388- 2442.
  • 9JUG B,SALOBIR BG,VENE N, et al. Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure[J]. Heart Vessels,2009,24(4) :271-276.
  • 10NISSEN SE,TUZCU EM, SCHOENHAGEN P,et al. Statin therapy, LDL cholesterol, C-reactive protein and coronary artery disease [ J ]. N Engl J Med,2005,352 ( 1 ) :29-38.

共引文献71

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部